Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Feb 14;8(7):12417-12432.
doi: 10.18632/oncotarget.13778.

Developmental therapeutics for inflammatory breast cancer: Biology and translational directions

Affiliations
Review

Developmental therapeutics for inflammatory breast cancer: Biology and translational directions

Ricardo Costa et al. Oncotarget. .

Abstract

Inflammatory breast cancer (IBC) is a rare and aggressive form of breast cancer, which accounts for approximately 3% of cases of breast malignancies. Diagnosis relies largely on its clinical presentation, and despite a characteristic phenotype, underlying molecular mechanisms are poorly understood. Unique clinical presentation indicates that IBC is a distinct clinical and biological entity when compared to non-IBC. Biological understanding of non-IBC has been extrapolated into IBC and targeted therapies for HER2 positive (HER2+) and hormonal receptor positive non-IBC led to improved patient outcomes in the recent years. This manuscript reviews recent discoveries related to the underlying biology of IBC, clinical progress to date and suggests rational approaches for investigational therapies.

Keywords: immunotherapy; inflammatory breast cancer; targeted therapy.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST

The authors declare no potential conflicts of interest

Figures

Figure 1
Figure 1. The Myc interaction with the cell cycle machinery
this figure is a simplified depiction of the role Myc oncoprotein in regulation of the cell cycle machinery. The normal cell replication processes are represented i.e., G1 first growth period to S DNA replication phase, G2 second growth period, and M, which is the mitosis period. Cyclin D2-CDK4 and CDK2 inactivate retinoblastoma protein (Rb) through phosphorylation. The latter event allows for cell cycle progression from G1 to S phase. Max/Myc complex targets cyclinD2-CDK4 complex formation ultimately stimulating cell cycle progression. Also cycle dependent kinase 2 (CDK2) complex activation is depicted through the abrogation of inhibitory action of Cki27 by active Max/Myc complex. When active CDK2 complex promotes initiation of S phase.

References

    1. Levine PH, Veneroso C. The epidemiology of inflammatory breast cancer. Semin Oncol. 2008;35:11–6. doi: 10.1053/j.seminoncol.2007.11.018. - DOI - PubMed
    1. Anderson WF, Schairer C, Chen BE, Hance KW, Levine PH. Epidemiology of inflammatory breast cancer (IBC) Breast Dis. 2005;22:9–23. doi: - PMC - PubMed
    1. Goldner B, Behrendt CE, Schoellhammer HF, Lee B, Chen SL. Incidence of inflammatory breast cancer in women, 1992-2009, United States. Ann Surg Oncol. 2014;21:1267–70. doi: 10.1245/s10434-013-3439-y. - DOI - PMC - PubMed
    1. Haagensen CD. Diseases of the female breast. Trans N Engl Obstet Gynecol Soc. 1956;10:141–56. doi: - PubMed
    1. Dawood S, Merajver SD, Viens P, Vermeulen PB, Swain SM, Buchholz TA, Dirix LY, Levine PH, Lucci A, Krishnamurthy S, Robertson FM, Woodward WA, Yang WT, et al. International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Ann Oncol. 2011;22:515–23. doi: 10.1093/annonc/mdq345. - DOI - PMC - PubMed

MeSH terms